Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.70 |
| ▸ | MEN1 | O00255 | 5/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | GAA | P10253 | 1/20 | 0.70 |
| ▸ | XBP1 | P17861 | 1/20 | 0.70 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.63 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.63 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.63 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29485038 | 1.00 | MAPT (0.70) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL3045461 | 0.95 | MAPT (0.65) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL6410568 | 0.89 | MAPT (0.65) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL433736 | 0.89 | MEN1 (0.71) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL31236338 | 0.88 | MAPT (0.77) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL5142590 | 0.88 | MAPT (0.77) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL693942 | 0.85 | MAPT (0.72) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL693941 | 0.85 | MAPT (0.72) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL26627751 | 0.85 | MAPT (0.72) | MAPTMEN1KMT2AGAAXBP1 | |
| SCHEMBL2184782 | 0.84 | SMN1; SMN2 (0.71) | MAPTMEN1KMT2AGAAXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12623942-B2 | Method for extracting salts and temperature- regenerated extracting composition | ADIONICS (FR) | 2026-05-12 | — | — | US | disclosed |
| EP-4061961-B1 | METHOD FOR DOUBLE STRAND SEQUENCING | OXFORD NANOPORE TECH PLC (GB) | 2026-04-08 | — | — | EP | disclosed |
| US-20260072009-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-12 | — | — | US | disclosed |
| US-20260063618-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | Oxford Nanopore Technolgies PLC (GB) | 2026-03-05 | — | — | US | disclosed |
| EP-4270008-B1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECH PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| EP-4127711-B1 | METHOD OF DETECTING AN ANALYTE IN A MEDIUM COMPRISING A LIGHT SCATTERING CONSTITUENT | KING S COLLEGE LONDON (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-4662489-A1 | METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE | Oxford University Innovation Limited (GB) | 2025-12-17 | — | — | EP | disclosed |
| US-20250361552-A1 | METHOD AND ADAPTORS | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-11-27 | — | — | US | disclosed |
| EP-4168582-B1 | A METHOD OF SELECTIVELY CHARACTERISING A POLYNUCLEOTIDE USING A DETECTOR | OXFORD NANOPORE TECH PLC (GB) | 2025-11-19 | — | — | EP | disclosed |
| US-20250164497-A1 | METHOD OF CHARACTERISING POLYPEPTIDES USING A NANOPORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-05-22 | — | — | US | disclosed |
| US-20060287377-A1 | New benzimidazole derivatives | ASTRAZENECA AB (SE) | 2006-12-21 | — | — | US | disclosed |
| CN-1784387-A | Novel benzimidazole derivatives | ASTRAZENECA AB (SE) | 2006-06-07 | — | — | CN | disclosed |
| EP-1660467-A2 | AMINOFURAZAN COMPOUNDS AS PROTEIN KINASE INHIBITORS | Vertex Pharmaceuticals Incorporated (US) | 2006-05-31 | — | — | EP | disclosed |
| EP-1626964-A2 | NEW BENZIMIDAZOLE DERIVATIVES | AstraZeneca AB (SE) | 2006-02-22 | — | — | EP | disclosed |
| US-20050148640-A1 | Aminofurazan compounds useful as protein kinase inhibitors | VERTEX PHARMACEUTICALS INCORPORATED | 2005-07-07 | — | — | US | disclosed |
| WO-2005019190-A2 | (4 -AMINO -1,2, 5-OXADIAZOL-4-YL) -HETΞROAROMATIC COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2005-03-03 | — | — | WO | disclosed |
| WO-2004100865-A2 | NEW BENZIMIDAZOLE DERIVATIVES | ASTRAZENECA AB (SE) | 2004-11-25 | — | — | WO | disclosed |
| US-4944796-A | Certain 2-(disubstituted amino) acetanilide herbicides | ICI AMERICAS INC. (US) | 1990-07-31 | — | — | US | disclosed |
| US-4891058-A | HERBICIDALLY ACTIVE INTERMEDIATES | ICI AMERICAS INC. (US) | 1990-01-02 | — | — | US | disclosed |
| US-4102924-A | REACTING ACYLAMINO-ARYLS WITH HALO-ARYLS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287377-A1 | New benzimidazole derivatives | CYP2C9, CDK9, CCNI | MAPT 2393/4885MEN1 1947/4885KMT2A 2653/4885 |
| US-20050148640-A1 | Aminofurazan compounds useful as protein kinase inhibitors | PHKG1, MAP3K20, MAP3K5 | MAPT 1028/4885MEN1 2135/4885KMT2A 1498/4885 |
| US-20260063618-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | NUP210, NPPA, NUP160 | MAPT 2543/4885MEN1 1352/4885KMT2A 4744/4885 |
| US-12623942-B2 | Method for extracting salts and temperature- regenerated extracting composition | POLQ, NONO, AQP3 | MAPT 3057/4885MEN1 4052/4885KMT2A 2402/4885 |
| US-20260072009-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | NUP210, SLC9A2, SLC9A3 | MAPT 2784/4885MEN1 446/4885KMT2A 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.